Allied respiratory professionals Cooper B.G., Troosters T., Burge G., Field D., Hrafnkelsdottir S.S., Pitta F., Lloyd J.K., Steenbuggen I. Eur Respir J 2010; 36: 701-703 | |
The continuing challenge of air pollution Brunekreef B. Eur Respir J 2010; 36: 704-705 | |
Tainted eponyms in medicine: the “Clara” cell joins the list Woywodt A., Lefrak S., Matteson E. Eur Respir J 2010; 36: 706-708 | |
Rho kinase inhibitors for pulmonary hypertension: waiting for clinical evidence Pacaud P., Loirand G. Eur Respir J 2010; 36: 709-711 | |
The paradox in pneumococcal serotypes: highly invasive does not mean highly lethal Pletz M.W., Welte T., Klugman K.P. Eur Respir J 2010; 36: 712-713 | |
The European Respiratory Journal targets tuberculosis Lange C., Yew W.W., Migliori G.B., Raviglione M. Eur Respir J 2010; 36: 714-715 | |
Lung development, lung growth and the future of respiratory medicine Ranganathan S. Eur Respir J 2010; 36: 716-717 | |
The light at the end of the tunnel: is COPD prevalence changing? Celli B.R. Eur Respir J 2010; 36: 718-719 | |
What makes large epidemiological studies comparable? Cerveri I., De Marco R. Eur Respir J 2010; 36: 720-721 | |
The Clara cell: a “Third Reich eponym”? Winkelmann A., Noack T. Eur Respir J 2010; 36: 722-727 | |
Factors influencing duration of exposure with symptoms and costs of occupational asthma Miedinger D., Malo J-L., Ghezzo H., L'Archevêque J., Zunzunegui M-V. Eur Respir J 2010; 36: 728-734 | |
Application of a prediction model for work-related sensitisation in bakery workers Meijer E., Suarthana E., Rooijackers J., Grobbee D.E., Jacobs J.H., Meijster T., de Monchy J.G.R., van Otterloo E., van Rooy F.G.B.G.J., Spithoven J.J.G., Zaat V.A.C., Heederik D.J.J. Eur Respir J 2010; 36: 735-742 | |
The occupational contribution to severe exacerbation of asthma Henneberger P.K., Mirabelli M.C., Kogevinas M., Antó J.M., Plana E., Dahlman- Höglund A., Jarvis D.L., Kromhout H., Lillienberg L., Norbäck D., Olivieri M., Radon K., Torén K., Urrutia I., Villani S., Zock J.P. Eur Respir J 2010; 36: 743-750 | |
Inhaled corticosteroid use is associated with lower mortality for subjects with COPD and hospitalised with pneumonia Malo de Molina R., Mortensen E.M., Restrepo M.I., Copeland L.A., Pugh M.J.V., Anzueto A. Eur Respir J 2010; 36: 751-757 | |
Recent trends in COPD prevalence in Spain: a repeated cross-sectional survey 1997-2007 Soriano J.B., Ancochea J., Miravitlles M., García-Río F., Duran-Tauleria E., Muñoz L., Jiménez-Ruiz C.A., Masa J.F., Viejo J.L., Villasante C., Fernández-Fau L., Sánchez G., Sobradillo-Peña V. Eur Respir J 2010; 36: 758-765 | |
No increase in the prevalence of COPD in two decades Vasankari T.M., Impivaara O., Heliövaara M., Heistaro S., Liippo K., Puukka P., Saarelainen S., Kanervisto M., Jousilahti P. Eur Respir J 2010; 36: 766-773 | |
Impact of dietary shift to higher-antioxidant foods in COPD: a randomised trial Keranis E., Makris D., Rodopoulou P., Martinou H., Papamakarios G., Daniil Z., Zintzaras E., Gourgoulianis K.I. Eur Respir J 2010; 36: 774-780 | |
Plasmacytoid dendritic cells in pulmonary lymphoid follicles of patients with COPD Van Pottelberge G.R., Bracke K.R., Van den Broeck S., Reinartz S.M., van Drunen C.M., Wouters E.F., Verleden G.M., Vermassen F.E., Joos G.F., Brusselle G.G. Eur Respir J 2010; 36: 781-791 | |
Riociguat for chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension: a phase II study Ghofrani H.A., Hoeper M.M., Halank M., Meyer F.J., Staehler G., Behr J., Ewert R., Weimann G., Grimminger F. Eur Respir J 2010; 36: 792-799 | |
Fasudil reduces monocrotaline-induced pulmonary arterial hypertension: comparison with bosentan and sildenafil Mouchaers K.T.B., Schalij I., de Boer M.A., Postmus P.E., van Hinsbergh V.W.M., van Nieuw Amerongen G.P., Vonk Noordegraaf A., van der Laarse W.J. Eur Respir J 2010; 36: 800-807 | |
Therapeutic efficacy of azaindole-1 in experimental pulmonary hypertension Dahal B.K., Kosanovic D., Pamarthi P.K., Sydykov A., Lai Y-J., Kast R., Schirok H., Stasch J-P., Ghofrani H.A., Weissmann N., Grimminger F., Seeger W., Schermuly R.T. Eur Respir J 2010; 36: 808-818 | |
Elevated brain natriuretic peptide predicts mortality in interstitial lung disease Corte T.J., Wort S.J., Gatzoulis M.A., Engel R., Giannakoulas G., Macdonald P.M., Wells A.U. Eur Respir J 2010; 36: 819-825 | |
The impact of a delay in intensive care unit admission for community-acquired pneumonia Phua J., Ngerng W.J., Lim T.K. Eur Respir J 2010; 36: 826-833 | |
Influence of genetic ancestry on the risk of obstructive sleep apnoea syndrome Guindalini C., Colugnati F.A.B., Pellegrino R., Santos-Silva R., Bittencourt L.R.A., Tufik S. Eur Respir J 2010; 36: 834-841 | |
Is tidal expiratory flow limitation predictive of sleep-related disorders in the elderly? Guillot M., Costes F., Sforza E., Maudoux D., Bertoletti L., Barthélémy J.C., Roche F. Eur Respir J 2010; 36: 842-848 | |
Pregnancy and fetal outcomes of symptoms of sleep-disordered breathing Bourjeily G., Raker C.A., Chalhoub M., Miller M.A. Eur Respir J 2010; 36: 849-855 | |
Serotype-specific pneumococcal disease may be influenced by mannose-binding lectin deficiency Vallès X., Roca A., Lozano F., Morais L., Suárez B., Casals F., Mandomando I., Sigaúque B., Nhalungo D., Esquinas C., Quintó L., Alonso P.L., Torres A. Eur Respir J 2010; 36: 856-863 | |
Characteristics of hospitalised patients with 2009 H1N1 influenza in Chile Riquelme R., Riquelme M., Rioseco M.L., Inzunza C., Gomez Y., Contreras C., Riquelme J., Peyrani P., Wiemken T., Ramirez J. Eur Respir J 2010; 36: 864-869 | |
Predicting outcomes and drug resistance with standardised treatment of active tuberculosis Oxlade O., Schwartzman K., Pai M., Heymann J., Benedetti A., Royce S., Menzies D. Eur Respir J 2010; 36: 870-877 | |
Ongoing tuberculosis transmission to children in Greenland Soborg B., Koch A., Thomsen V.Ø. , Ladefoged K., Andersson M., Wohlfahrt J., Melbye M., Andersen A.B. Eur Respir J 2010; 36: 878-884 | |
Plasma DNA level in predicting therapeutic efficacy in advanced nonsmall cell lung cancer Kumar S., Guleria R., Singh V., Bharti A.C., Mohan A., Das B.C. Eur Respir J 2010; 36: 885-892 | |
Systemic sclerosis and bilateral lung transplantation: a single centre experience Saggar R., Khanna D., Furst D.E., Belperio J.A., Park G.S., Weigt S.S., Kubak B., Ardehali A., Derhovanessian A., Clements P.J., Shapiro S., Hunter C., Gregson A., Fishbein M.C., Lynch III J.P., Ross D.J., Saggar R. Eur Respir J 2010; 36: 893-900 | |
An experimental model of pneumonia induced by methicillin-resistant Staphylococcus aureus in ventilated piglets Martínez-Olondris P., Sibila O., C. Agustí, Rigol M., Soy D., Esquinas C., Piñer R., Luque N., Guerrero L., Quera M.Á., Marco F., de la Bellacasa J.P., Ramirez J., Torres A. Eur Respir J 2010; 36: 901-906 | |
Overexpression of transforming growth factor-β1 in fetal monkey lung results in prenatal pulmonary fibrosis Tarantal A.F., Chen H., Shi T.T., Lu C-H., Fang A.B., Buckley S., Kolb M., Gauldie J., Warburton D., Shi W. Eur Respir J 2010; 36: 907-914 | |
Current data on predictive markers for anti-angiogenic therapy in thoracic tumours Reinmuth N., Thomas M., Meister M., Schnabel P.A., Kreuter M. Eur Respir J 2010; 36: 915-924 | |
Tuberculosis contact investigation in low prevalence countries: a European consensus Erkens C.G.M., Kamphorst M., Abubakar I., Bothamley G.H., Chemtob D., Haas W., Migliori G.B., Rieder H.L., Zellweger J-P., Lange C. Eur Respir J 2010; 36: 925-949 | |
Epigenetic mechanisms and the relationship to childhood asthma Kabesch M., Michel S., Tost J. Eur Respir J 2010; 36: 950-961 | |
Occupational asthma to solder wire containing an adipic acid flux Moore V.C., Burge P.S. Eur Respir J 2010; 36: 962-963 | |
Response to salbutamol in patients with mild asthma treated with nadolol Hanania N.A., Mannava B., Franklin A.E., Lipworth B.J., Williamson P.A., Garner W.J., Dickey B.F., Bond R.A. Eur Respir J 2010; 36: 963-965 | |
Endobronchial metallic clips to guide high-dose external-beam radiotherapy in radio-occult lung cancer Malfait T., van Eijkeren M., van Meerbeeck J.P., Tournoy K.G. Eur Respir J 2010; 36: 965-967 | |
Iloprost-induced thrombocytopenia: a case proven by rechallenge Taegtmeyer A.B., Zettler C., Siegemund M., Tsakiris D.A., Rätz Bravo A.E., Pargger H., Kraehenbuehl S., Haschke M. Eur Respir J 2010; 36: 967-969 | |
Azithromycin treatment failure in macrolide-resistant Mycoplasma pneumoniae pneumonia To K.K.W., Chan K-H., Fung Y-F., Yuen K-Y., Ho P-L. Eur Respir J 2010; 36: 969-971 | |
Assessment of bronchoreversibility in severe emphysema Hansen J.E. Eur Respir J 2010; 36: 972 | |
From the authors: Han M.K., Martinez F.J. Eur Respir J 2010; 36: 973 | |
Inhaled corticosteroids: a controversial add-on treatment in COPD Puhan M.A. Eur Respir J 2010; 36: 973-974 | |
From the authors: Singh S., Loke Y.K. Eur Respir J 2010; 36: 974 | |
From the authors Sin D.D., Man S.F.P. Eur Respir J 2010; 36: 974-975 | |